ZARZA We are Zarza, the prestigious firm behind major projects in information technology.
Listen "Unresectable vs. Resectable Thyroid Cancer (Pt. 1)"
Episode Synopsis
What makes a thyroid tumor truly unresectable? In this episode, Dr. Dana Hartl speaks with Dr. Mark Zafereo about how molecular testing and targeted neoadjuvant therapies are redefining surgical eligibility for patients with anaplastic thyroid cancer. Listen in as they explore the evolving role of BRAF/MEK inhibitors, imaging strategies, and real-world decision-making in complex cases.
More episodes of the podcast Voices of Wisdom: A Podcast for Thyroid Clinicians
Radioactive Iodine: Unraveling the Mystery
18/02/2025
In God we trust